Le Lézard
Classified in: Health
Subject: SVY

The radiodermatitis treatment market will register a CAGR of over 4% by 2023

NEW YORK, May 21, 2019 /PRNewswire/ -- About this market

Several rising initiatives by research institutes are impacting the radiodermatitis treatment market growth during the forecast period. Existing vendors are further striving to evaluate the therapeutic efficacy of a wide range of radiodermatitis treatment products for leveraging their product portfolio. Researchers from different universities are using low-intensity laser therapy in breast cancer patients for preventing and controlling the symptoms of this health condition. As a result, initiatives by several research institutes will lead to the radiodermatitis treatment market growth during the forecast period. Analysts have predicted that the radiodermatitis treatment market will register a CAGR of over 4% by 2023.

Read the full report: https://www.reportlinker.com/p05777290/?utm_source=PRN

Market Overview

The rising number of public and private healthcare organizations

Promoting awareness about radiodermatitis diagnosis and treatment and increasing the adoption of radiodermatitis products. This will drive the growth of the market during the forecast period.

Advent of novel radiation equipment with fewer side-effects

The global radiodermatitis treatment market is currently witnessing the advent of novel radiation equipment with fewer side-effects, leading to a decrease in demand for radiodermatitis drugs, thereby hindering the market growth.

For the detailed list of factors that will drive and challenge the growth of the radiodermatitis treatment market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Several vendors are focusing on the concept of moisture therapy, which involves moisturizing the wound area to promote natural cell repair while giving the injured cells sufficient time to recover. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Read the full report: https://www.reportlinker.com/p05777290/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


SOURCE Reportlinker

These press releases may also interest you

at 16:10
Arbutus Biopharma Corporation , an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced preliminary results from a Phase 1a/1b clinical trial in healthy subjects and two cohorts of chronic...

at 16:05
NuVasive, Inc. , the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its second quarter 2019 earnings results on...

at 16:05
Aevi Genomic Medicine, Inc. today announced it has entered into an exclusive license agreement with OSI Pharmaceuticals, LLC, an indirect wholly-owned subsidiary of Astellas Pharma Inc. ("Astellas") for the worldwide development and...

at 16:00
A June 24 article on Detroit Free Press warns of the potential dangers of charcoal toothpaste, namely that it is just as likely to remove enamel as stains. While the article admits that more studies need to be conducted before charcoal toothpastes...

at 15:30
The "Diabetes Management: Insulin Pumps Market" report has been added to ResearchAndMarkets.com's offering. Valued at nearly $3bn in 2017, the Insulin Pumps Market is growing at nearly 10%, one of the highest growth medical device markets...

at 15:15
The "Hemodialysis & Peritoneal Dialysis Market by Product (Machines, Dialyzers, Concentrates, Dialysates, Catheters) Services, Modality (Conventional, CAPD, Nocturnal), End User - Global Forecasts to 2024" report has been added to...

News published on 21 may 2019 at 19:02 and distributed by: